Pascal Neuville

Founder at

Peptimimesis SAS

62 year

16 connections

Health Technology

Consumer Services

Health Services

Profile

Pascal Neuville is the founder of Domain Therapeutics SA, founded in 2001, and Peptimimesis SAS, founded in 2015, where the title held is Chairman.
Current jobs include Chairman at Axilum Robotics SAS, Director at Mavalon Therapeutics Ltd. since 2018, and Director at Find Therapeutics.
Former jobs include Head-Research & Development Project at Transgene SA from 2008 to 2008, Professor at the University of Geneva, and President of Alsace BioValley Association from 2009 to 2010.
Education includes a doctorate from the University of Strasbourg.

Pascal Neuville active positions

Companies	Position	Start
Axilum Robotics SAS Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures	Chairman	-
Peptimimesis SAS Peptimimesis SAS BiotechnologyHealth Technology Provides biotechnology research services	Founder	01/10/2015
Find Therapeutics Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases	Director/Board Member	-
Mavalon Therapeutics Ltd. Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients	Director/Board Member	01/07/2018

All active positions of Pascal Neuville

Former positions of Pascal Neuville

Companies	Position	End
Alsace BioValley Association Alsace BioValley Association Medical/Nursing ServicesHealth Services Operates as health innovation center	President	01/01/2010
TRANSGENE	Corporate Officer/Principal	01/01/2008
University of Geneva University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Founder	-

See the detail of Pascal Neuville's experience

Training of Pascal Neuville

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pascal Neuville's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Transgene SA Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer	Health Technology
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Health Technology
University of Geneva University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Strasbourg University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alsace BioValley Association Alsace BioValley Association Medical/Nursing ServicesHealth Services Operates as health innovation center	Health Services
Axilum Robotics SAS Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures	Commercial Services
Peptimimesis SAS Peptimimesis SAS BiotechnologyHealth Technology Provides biotechnology research services	Health Technology
Mavalon Therapeutics Ltd. Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients	Health Technology
Find Therapeutics Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases	Health Technology